These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 26123901

  • 1. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
    Liu C.
    Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
    Li LN, Zhou X, Gu Y, Yan J.
    Asian Pac J Cancer Prev; 2013 Aug; 14(7):4107-13. PubMed ID: 23991961
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
    Jia H, Zhang Q, Liu F, Zhou D.
    Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
    Gao GL, Liu LD, Zou XS, Chen WX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
    Desmeules P, Trudel D, Turcotte S, Sirois J, Plante M, Grégoire J, Renaud MC, Orain M, Têtu B, Bairati I.
    Hum Pathol; 2015 May; 46(5):739-45. PubMed ID: 25771900
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
    Miao S, Zhou SY, Han CS, Zhang LN, Sun HB, Yang B.
    Drug Des Devel Ther; 2015 May; 9():3729-40. PubMed ID: 26229436
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications.
    Garzetti GG, Ciavattini A, Lucarini G, Goteri G, de e Nictolis M, Garbisa S, Masiero L, Romanini C, Graziella B.
    Anticancer Res; 1995 May; 15(6B):2799-804. PubMed ID: 8669868
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Gayther S, Jacobs IJ, Høgdall CK.
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis.
    Liu C, Shen Y, Tan Q.
    Int J Biol Markers; 2023 Mar; 38(1):15-24. PubMed ID: 36448239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.